Clinical Trial Update: Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer [NA]

View source ↗

Summary

This clinical trial update discusses a study combining an Akkermansia muciniphila probiotic with an anti-PD-1 monoclonal antibody for MSS/pMMR advanced colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Akkermansia muciniphila probiotic (Akkermansia muciniphila)
• PD-1 inhibitor (anti-PD-1 monoclonal antibody) (PD-1 monoclonal antibody)

Snippet

Sponsor: West China Hospital | Conditions: Colo-rectal Cancer, PD-1 Inhibitor | NA | Status: ACTIVE_NOT_RECRUITING